$10.02
-0.32-3.09%
Last update: Nov 10, 4:00 PM
Biodesix Inc
BDSXNASDAQ
Biodesix rose 37.1% from $7.54 to $10.34, ahead of the S&P 500's +10.0%. Its worst day was Nov 6 (−57.0%), and its low came Jan 9 at $5.46.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Biodesix closed at its lowest level of the year, 27.6% below where the year started.
−2.2% · S&P 500 +0.7%
Biodesix shares rose 22.4%, while the S&P 500 rose 1.2%.
+22.4% · S&P 500 +1.2%
Story events cover the past 12 months · Times ET
EPS of $-0.49 beat the $-0.94 estimate on $28.8M revenue (est. $25.8M); FY revenue guidance of $106.0M–$112.0M against the $105.1M consensus.
+7.8% · S&P 500 −0.5%
EPS of $-0.81 beat the $-1.13 estimate on $25.6M revenue (est. $23.1M); FY revenue guidance of $108.0M–$114.0M against the $108.7M consensus.
+32.6% · S&P 500 +0.8%
EPS of $-0.71 beat the $-0.89 estimate on $26.9M revenue (est. $25.9M); FY revenue guidance of $108.0M–$114.0M against the $110.9M consensus.
−3.0% · S&P 500 −0.2%
Biodesix closed at its highest level of the year, 305.8% above where the year started.
+9.0% · S&P 500 0.0%
EPS of $-0.75 beat the $-0.75 estimate on $24.0M revenue (est. $27.4M); FY revenue guidance of $101.0M–$103.0M against the $111.7M consensus.
−57.0%, the year's worst day · S&P 500 +0.3%
Where it ended: a close of $10.34 on Nov 9, 2026. Up next: Q4 2026 earnings on Feb 25, 2027 (EPS est. $-0.48, revenue est. $28.5M).
Nothing in the past 12 months.
All BDSX dividend historyReplay the year: the line draws itself and stops at each of the 7 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for BDSX and SPY from Benzinga historical bars. Not investment advice.
